Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor, April 2001–October 2001 and October 2001–May 2002

Scott McCormick made this Freedom of Information request to Therapeutic Goods Administration

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

Therapeutic Goods Administration did not have the information requested.

Dear Therapeutic Goods Administration,

I request release of all correspondence from ADF, AMI and ADHREC (ADMEC) with regard to the ADF Mefloquine and doxycycline malaria prophylaxis trial in Australian soldiers in East Timor, April 2001–October 2001 and October 2001–May 2002.

https://www.mja.com.au/journal/2005/182/...

I also request any correspondence with regard to amendments in this particular trial protocol.

Given the increased Senate scrutiny of this trial I also request that costs of processing the above application be waived on public interest grounds.

Yours faithfully,
Scott McCormick

TGA FOI, Therapeutic Goods Administration

1 Attachment

Dear Mr McCormick

FREEDOM OF INFORMATION REQUEST – NOTIFICATION OF RECEIPT

I am writing to notify you that the Department of Health (Department) has
received your request for access to documents under the Freedom of
Information Act 1982 (FOI Act).

Under section 15(5)(b) of the FOI Act, the agency has 30 calendar days
after the date your request was received in which to provide a decision in
response to your request for access.

A decision is currently due on or before 16 October 2018.

However, where there is requirement to undertake consultation with
affected third parties, this timeframe is extended by a further 30 days.
It may also be extended in certain circumstances, including with your
agreement or where the Department applies to the Office of the Australian
Information Commissioner for an extension].

 

In addition, please note that if the decision maker decides that you are
liable to pay a charge in relation to your request then this timeframe is
extended pending payment of a deposit.

 

You will be notified by the agency if charges are liable to pay a charge
and/or if third party consultation is required.

any queries, you can contact the FOI team on (02) 6232 8720, or via email
at [1][email address].

Kind regards

Heather

 

Freedom of Information
Karen | Heather | Tara

(02) 6232 8772

Reporting and Collaboration Services Section

Regulatory Engagement and Planning Branch

Therapeutic Goods Administration
Address: PO Box 100, Woden ACT, 2606
Email: [2][email address]

 

[3]cid:image001.png@01D1D5D9.7DDEADA0

 

 

--------------------------------------------------------------------------

"Important: This transmission is intended only for the use of the
addressee and may contain confidential or legally privileged information.
If you are not the intended recipient, you are notified that any use or
dissemination of this communication is strictly prohibited. If you receive
this transmission in error please notify the author immediately and delete
all copies of this transmission."

References

Visible links
1. mailto:[email address]
2. mailto:[email address]

hide quoted sections

TGA FOI, Therapeutic Goods Administration

3 Attachments

Dear Mr McCormick

 

Please find attached correspondence in relation to your Freedom of
Information request.

 

If you have any questions, please do not hesitate to contact the FOI Team.

 

Kind regards

Tara

Freedom of Information
(02) 6232 8772

Reporting and Collaboration Services Section

Regulatory Engagement and Planning Branch

Therapeutic Goods Administration
Address: PO Box 100, Woden ACT, 2606
Email: [1][email address]

 

[2]cid:image001.png@01D1D5D9.7DDEADA0

 

 

 

--------------------------------------------------------------------------

"Important: This transmission is intended only for the use of the
addressee and may contain confidential or legally privileged information.
If you are not the intended recipient, you are notified that any use or
dissemination of this communication is strictly prohibited. If you receive
this transmission in error please notify the author immediately and delete
all copies of this transmission."

References

Visible links
1. mailto:[email address]

hide quoted sections